InvestorsHub Logo
Followers 532
Posts 31795
Boards Moderated 2
Alias Born 09/23/2010

Re: None

Wednesday, 10/11/2017 11:57:26 AM

Wednesday, October 11, 2017 11:57:26 AM

Post# of 589
ATMS shows news on their website; they attended Rodman & Renshaw Investment Conference in September. Today's filing showing new institutional owner Michael Vasinkevich (Acumen) 13%
https://www.otcmarkets.com/financialReportViewer?symbol=ATMS&id=180565

If you google Michael Vasinkevich, you will find that he is the founding partner of Rodman & Renshaw Capital Group. News all pointing to Rodman & Renshaw Investment. Coincidence ?

Mr. Michael Vasinkevich serves as Senior Managing Director, Vice Chairman and Founding Partner of Rodman & Renshaw Capital Group, Inc., and served as its Senior Managing Director since July 2002.

Artemis Presentation Webcast – Rodman & Renshaw 19th Annual Global Investment Conference
Brian M. Culley, CEO of Artemis Therapeutics Inc. (OTCMKTS: ATMS), presents on the company at the Rodman & Renshaw 19th Annual Global Investor Conference.

Click here to view the webcast
Post navigation
http://www.artemis-therapeutics.com/2017/09/12/artemis-presentation-webcast-rodman-renshaw-19th-annual-global-investment-conference/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MNKA News